Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-16-000136
Filing Date
2016-01-14
Accepted
2016-01-14 15:22:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A AEZS 1.14.16 aezs0116.txt SC 13G/A 13579
  Complete submission text file 0001535610-16-000136.txt   15272
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211
Aeterna Zentaris Inc. (Subject) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51184 | Film No.: 161342847
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A